不同类型的癌症相关血栓瘤的临床和实验室特征
Yanhong Liu1, Rufei Ma1, Yue Li1
1Department of Laboratory Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, Henan, 450003, China.
Journal of Cancer
|November 29, 2023
概括
癌症患者面临高风险的静脉血栓栓塞 (VTE). 这项研究揭示了胃肠道,肺部和妇科癌症的独特VTE风险因素和实验室发现,强调了定制的预防策略.
科学领域:
- 在瘤学瘤学.
- 血液学 血液学 血液学
- 临床医学 临床医学
背景情况:
- 静脉血栓塞栓症 (VTE) 是癌症患者的重大并发症,通常与预后不佳有关.
- 特定的风险因素和VTE的临床表现可能因癌症类型而异.
- 了解这些差异对于在瘤学中有效管理VTE至关重要.
研究的目的:
- 在不同类型的癌症中调查和比较癌症患者的临床特征和实验室测试结果.
- 确定与胃肠道,肺部和妇科癌症中VTE相关的独特风险因素和结果.
- 为制定量身定制的VTE预防和治疗策略提供信息.
主要方法:
- 2014年至2020年期间在河南省人民医院诊断出VTE的癌症患者的临床数据的回顾性分析.
- 在患有胃肠道,肺部和妇科癌症的患者中,比较人口统计数据,临床特征 (例如手术率) 和实验室参数 (例如红细胞,HGB,RDW,PT,APTT).
- 评估结果,包括停留时间 (LOS),成功治疗率,VTE治愈率和出院后的抗凝剂使用.
主要成果:
- 胃肠道 (GI) 癌症,肺癌和妇科癌症是VTE患者中最常见的类型.
- 与肺癌患者相比,肠道和妇科癌症患者的外科手术发生率明显高 (P<0.001).
- 独特的实验室发现包括在妇科癌症中较低的红细胞和HGB,在胃肠癌中较高的RDW,在妇科癌症中较短的PT,在肺癌中较长的APTT.
- 虽然LOS和成功治疗率相似,但VTE治愈率在妇科癌症 (90.3%) 中高于肠道癌症 (61.2%) (P=0.005).
- 出院后抗凝剂的使用在妇科癌症患者 (6.5%) 与GI (30.6%) 和肺癌 (32.3%) 患者相比较低 (P<0.05).
结论:
- 静脉血栓栓塞的风险因素和实验室资料在不同类型的癌症中表现出显著的差异.
- 这项研究强调了基于特定癌症特征的VTE预防和治疗需要个性化的方法.
- 根据癌症类型量身定制干预措施可能会改善VTE结果,例如治愈率,并优化长期管理策略.
更多相关视频
05:17Micromanipulation of Circulating Tumor Cells for Downstream Molecular Analysis and Metastatic Potential Assessment
Published on: May 14, 2019
8.6K
14:14Adaptation of Semiautomated Circulating Tumor Cell CTC Assays for Clinical and Preclinical Research Applications
Published on: February 28, 2014
15.9K
相关概念视频
02:30Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K
01:21Cancer Survival Analysis
356
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
356
02:53Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
01:24Disorders of Hemostasis
926
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
926
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
711
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
711
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K